AbstractObjectivesThe multi‐hole self‐expandable metal stent (MHSEMS) is a novel SEMS with multiple small side holes on the covering membrane to prevent stent migration while minimizing tumor ingrowth. This study aimed to evaluate the clinical outcomes of MHSEMS in comparison with conventional covered SEMS (c‐CMS).MethodsConsecutive patients with unresectable pancreatic cancer who underwent initial SEMS placement (MHSEMS or c‐CMS) for malignant distal biliary obstruction were analyzed. Technical success, clinical success, causes of recurrent biliary obstruction (RBO), non‐RBO adverse events, time to RBO (TRBO), and endoscopic reintervention were compared between groups.ResultsA total of 65 patients were included (MHSEMS: 27, c‐CMS: 38). The technical success, clinical success, and non‐RBO adverse event rates were similar between groups. Although stent migration was less frequently observed in the MHSEMS group (0% vs. 17.6%, p = 0.032), overall RBO rates were similar between groups (53.8% vs. 55.9%, p > 0.99). The most common cause of RBO within 14 days in the MHSEMS group was non‐occlusion cholangitis. Median TRBO was significantly shorter in the MHSEMS group (101 vs. 227 days, p = 0.030) and MHSEMS was an independent predictor for shorter TRBO in multivariate analysis (hazard ratio, 2.27; 95% confidence interval, 1.06–4.86; p = 0.034). Outcomes after endoscopic interventio were not significantly different between groups. Stent removal was successful in all attempted cases in both groups.ConclusionsMHSEMS was associated with a significantly shorter TRBO compared to c‐CMS. Further modifications of the present MHSEMS may be needed.